Bristol Myers leans on new launches to offset legacy drug declines, while GSK's diverse portfolio and strong HIV lineup keep growth on track.

The Nigerian government has reduced the cost of dialysis for kidney patients from N50,000 to N12,000 per session at federal ...

The Business Research Company The Business Research Company's Pediatric Asthma Treatment Global Market Report 2025 – Market Size, Trends, A ...

A federal judge tripled damages against the pharmacy benefits manager after finding it encouraged inflated Medicare drug ...

The global Epiglottitis Treatment Market is projected to grow from USD 11.5 billion in 2025 to USD 18.4 billion by 2035, ...